Furthermore, in OLP, TGP suppresses abnormal T-cell activation and reduces mucosal inflammation by inhibiting the NF-κB and MAPKs pathways, thereby decreasing the release of pro-inflammatory cytokines and alleviating oxidative stress-induced tissue damage (Wang et al., 2016). This evidence concerns the gene NFKB1 and oral lichen planus.